Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S283000
Reexamination Certificate
active
07977346
ABSTRACT:
The present invention relates to spiro compounds of formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states such as cancers associated with protein tyrosine kinases, especially epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF), to their method of use as medicaments and to their method of use in the manufacture of medicaments for use in the production of inhibition of tyrosine kinase reducing effects in warm-blooded animals such as humans.
REFERENCES:
patent: 5137892 (1992-08-01), Chu
patent: 5591748 (1997-01-01), Badger
patent: 5770599 (1998-06-01), Gibson
patent: 6197974 (2001-03-01), Abbott
patent: 2002/0173501 (2002-11-01), Ledoussal
patent: 0341493 (1989-11-01), None
patent: 357047 (1990-03-01), None
patent: 611137 (1994-08-01), None
patent: 0623585 (1994-11-01), None
patent: 04342564 (1992-11-01), None
patent: 05221947 (1993-08-01), None
patent: 06145167 (1994-05-01), None
patent: 2002053536 (2002-02-01), None
patent: 2002069072 (2002-03-01), None
patent: 2002201191 (2002-07-01), None
patent: 2004099609 (2004-04-01), None
patent: WO9221659 (1992-12-01), None
patent: WO9510519 (1995-04-01), None
patent: WO9639407 (1996-12-01), None
patent: WO0153273 (2001-07-01), None
patent: WO03014108 (2003-02-01), None
patent: WO2005026165 (2005-03-01), None
patent: WO2006073167 (2006-07-01), None
patent: WO2006123767 (2006-11-01), None
patent: WO2006123792 (2006-11-01), None
patent: WO2007037330 (2007-04-01), None
Vippagunta et al., “Crystalline Solids”, Adv. Drug Del. Rev., 48 (2001) 3-26.
JMC 37, 3344(1994): Kimura, Youichi; ACS Publication.
Tetrahedron Letter, 41, 8173-8176; Storey, John; Elsevier Science Publication.
JACS, 119, 7625-7616 (1997); Yamaura, Yousuke; ACS Publication.
Heterocycles, 52, 595-598; Elsevier Science Publication.
Ward Paul V.
Wilson James O.
LandOfFree
Spiro compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670857